Clinical Trials Browser

Phase 2 × Metastatic Pancreatic Adenocarcinoma × regorafenib × Clear all

NCT02383433 2023-10-23

Regorafenib Plus Gemcitabine in Metastatic Pancreatic Cancer

Phase 2 Terminated

2 enrolled 8 charts

Gastrointestinal

Metastatic Pancreatic Adenocarcinoma